These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20859218)

  • 1. Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
    Kok MR; Vos K; Bos JD; Tak PP
    J Clin Rheumatol; 2010 Oct; 16(7):345. PubMed ID: 20859218
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
    Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
    Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
    [No Abstract]   [Full Text] [Related]  

  • 3. [Refractory subacute cutaneous lupus erythematosus treated with rituximab].
    Cieza-Díaz DE; Avilés-Izquierdo JA; Ceballos-Rodríguez C; Suárez-Fernández R
    Actas Dermosifiliogr; 2012; 103(6):555-7. PubMed ID: 22482740
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertrophic lupus erythematosus complicating long-standing systemic lupus erythematosus.
    Bernardi M; Bahrami S; Callen JP
    Lupus; 2011 Apr; 20(5):549-50. PubMed ID: 21300682
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab.
    Iwata S; Saito K; Tokunaga M; Yamaoka K; Nawata M; Yukawa S; Hanami K; Fukuyo S; Miyagawa I; Kubo S; Tanaka Y
    J Rheumatol; 2011 Apr; 38(4):633-41. PubMed ID: 21159836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in the treatment of bullous systemic lupus erythematosus.
    Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
    J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral manifestations of patients with lupus erythematosus.
    Brennan MT; Valerin MA; Napeñas JJ; Lockhart PB
    Dent Clin North Am; 2005 Jan; 49(1):127-41, ix. PubMed ID: 15567365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of recurrent pancreatitis secondary to systemic lupus erythematosus with B-cell depletion therapy.
    Al-Musawi ZS; Nabar UJ
    Arch Iran Med; 2011 Jan; 14(1):66-70. PubMed ID: 21194267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pancreatitis as initial manifestation of systemic lupus erythematosus and subacute cutaneous lupus erythematosus: report of two cases.
    Carducci M; Calcaterra R; Mussi A; Franco G; Morrone A
    Lupus; 2008 Jul; 17(7):695-7. PubMed ID: 18625645
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial.
    Lai JS; Beaumont JL; Ogale S; Brunetta P; Cella D
    J Rheumatol; 2011 Apr; 38(4):672-9. PubMed ID: 21239746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
    Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF
    Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.
    Hofmann SC; Leandro MJ; Morris SD; Isenberg DA
    Lupus; 2013 Aug; 22(9):932-9. PubMed ID: 23894047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report.
    Nellessen CM; Pöge U; Brensing KA; Sauerbruch T; Klehr HU; Rabe C
    Nephrol Dial Transplant; 2008 Jan; 23(1):385-6. PubMed ID: 17933839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erythema elevatum diutinum--a rare variant of skin changes in systemic lupus erythematosus].
    Schulze P; Audring H; Sönnichsen N
    Dermatol Monatsschr; 1989; 175(10):628-34. PubMed ID: 2591614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects on the morphology and pathogenesis of lupus erythematosus].
    Kerl H
    Z Hautkr; 1976 Feb; 51(4):143-62. PubMed ID: 9148609
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antimalarials in lupus erythematosus treatment].
    Woźniacka A
    Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
    Raptopoulou A; Linardakis C; Sidiropoulos P; Kritikos HD; Boumpas DT
    Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE.
    Iwata S; Saito K; Tokunaga M; Tanaka Y
    Ann Rheum Dis; 2012 Oct; 71(10):1749-50. PubMed ID: 22586167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.